Literature DB >> 21526983

MicroRNA profiling in cancer.

Reinhold Munker1, George A Calin.   

Abstract

The diagnosis of cancer has undergone major changes in the last 40 years. Once based purely on morphology, diagnosis has come to incorporate immunological, cytogenetic and molecular methods. Many cancers, especially leukaemias, are now defined by molecular markers. Gene expression profiling based on mRNA has led to further refinement of the classification and diagnosis of cancer. More recently, miRNAs (microRNAs), among other small non-coding RNA molecules, have been discovered and found to be major players in cell biology. miRNAs, having both oncogenic and tumour-suppressive functions, are dysregulated in many types of cancer. miRNAs also interfere with metastasis, apoptosis and invasiveness of cancer cells. In the present review, we discuss recent advances in miRNA profiling in human cancer. We discuss both frequent and rare tumour types and give an outlook on future developments.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21526983     DOI: 10.1042/CS20110005

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  72 in total

Review 1.  Making a long story short: noncoding RNAs and chromosome change.

Authors:  J D Brown; S E Mitchell; R J O'Neill
Journal:  Heredity (Edinb)       Date:  2011-11-09       Impact factor: 3.821

Review 2.  MicroRNA, nutrition, and cancer prevention.

Authors:  Sharon A Ross; Cindy D Davis
Journal:  Adv Nutr       Date:  2011-11-03       Impact factor: 8.701

Review 3.  The efficacy of miRNA122, a novel therapeutic target, for predicting the progression of hepatocellular carcinoma (HCC).

Authors:  Lifeng Wang; Zheng Zhang; Fu-Sheng Wang
Journal:  Cell Mol Immunol       Date:  2011-10-10       Impact factor: 11.530

Review 4.  Role of miRNAs in immune responses and immunotherapy in cancer.

Authors:  Maria Angelica Cortez; Simone Anfossi; Rishab Ramapriyan; Hari Menon; Semra Cemre Atalar; Maureen Aliru; James Welsh; George A Calin
Journal:  Genes Chromosomes Cancer       Date:  2019-04       Impact factor: 5.006

5.  MicroRNA-377 inhibited proliferation and invasion of human glioblastoma cells by directly targeting specificity protein 1.

Authors:  Rui Zhang; Hui Luo; Shuai Wang; Wanghao Chen; Zhengxin Chen; Hong-Wei Wang; Yuanyuan Chen; Jingmin Yang; Xiaotian Zhang; Wenting Wu; Shu-Yu Zhang; Shuying Shen; Qingsheng Dong; Yaxuan Zhang; Tao Jiang; Daru Lu; Shiguang Zhao; Yongping You; Ning Liu; Huibo Wang
Journal:  Neuro Oncol       Date:  2014-06-20       Impact factor: 12.300

6.  Prognostic potential of microRNA-138 and its target mRNA PDK1 in sera for patients with non-small cell lung cancer.

Authors:  Lihong Han; Guoxiu Zhang; Nali Zhang; Haiyan Li; Yanyan Liu; Aiguo Fu; Youguang Zheng
Journal:  Med Oncol       Date:  2014-07-27       Impact factor: 3.064

7.  Exploration of genome-wide circulating microRNA in hepatocellular carcinoma: MiR-483-5p as a potential biomarker.

Authors:  Jing Shen; Antai Wang; Qiao Wang; Irina Gurvich; Abby B Siegel; Helen Remotti; Regina M Santella
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-10-14       Impact factor: 4.254

8.  MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid Malignancies.

Authors:  Ronit Vogt Sionov
Journal:  ISRN Hematol       Date:  2013-01-29

9.  MicroRNA-744 promotes cell apoptosis via targeting B cell lymphoma-2 in gastric cancer cell line SGC-7901.

Authors:  Jixiang Liu; Yanlei Wei; Shouyong Li; Yujuan Li; Hongxiu Liu; Jingmei Liu; Xinxing Zhu
Journal:  Exp Ther Med       Date:  2018-08-13       Impact factor: 2.447

10.  MicroRNAs in hereditary diffuse gastric cancer.

Authors:  Mayra-Cecilia Suárez-Arriaga; Rosa-María Ribas-Aparicio; Martha-Eugenia Ruiz-Tachiquín
Journal:  Biomed Rep       Date:  2016-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.